Life sciences industry forecast for 2025 and beyond

Baker Tilly’s outlook on what lies ahead for industry leaders

As we close out 2024 and look ahead to 2025, the life sciences industry is facing growing challenges. Increasing regulatory scrutiny, evolving reimbursement models and pressures surrounding drug pricing are reshaping the landscape. Additionally, complexities in the healthcare provider (HCP) engagement process further complicate industry dynamics. Organizations must also navigate the impact of changing tax regulations and governance requirements, all while striving for innovation and maintaining compliance.

Join Baker Tilly for our fourth annual life sciences industry forecast webinar, where we will explore developments from this past year, discuss the current state of the environment and examine trends and challenges shaping the industry in 2025 and beyond, such as:

The state of capital markets and foundations for emerging companies to companies that are scaling globally in a competitive fundraising environment
The latest regulatory trends, including drug pricing and gross to net complexities
The importance of simplifying and standardizing HCP engagement
Evaluating KOLs and the impact on valuation
How to leverage technology to mitigate compliance risks
The value of evidence generation throughout the product lifecycle
How risks that are facing the industry can be turned into strategic opportunities

Attend this event to gain insights and tools to help your organization navigate challenges and seize opportunities in 2025 and beyond!

Who should attend?